The National Plan To Prevent Diabetic Kidney Disease Among Egyptians: A Prospective Multicenter Randomized Controlled Study
Overview
- Phase
- Not Applicable
- Intervention
- Gliflozin
- Conditions
- Diabetes Mellitus Without Complication
- Sponsor
- Fayoum University
- Enrollment
- 10000
- Primary Endpoint
- prevention of diabetic complications
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
Study of the possibility to prevent the development of Diabetic kidney disease in type 2 diabetic patients
Detailed Description
Study of the possible role of the SGLT2 inhibitors to prevent the development of frank type2 DM among prediabetic candidates. Study of the possible role of the SGLT2 inhibitors to prevent the development of diabetic complications, namely diabetic kidney disease, diabetic retinopathy and neuropathy.
Investigators
Ahmed Abdelkawi Hammad
Lecturer of internal medicine
Fayoum University
Eligibility Criteria
Inclusion Criteria
- •diabetics,prediabetics
Exclusion Criteria
- Not provided
Arms & Interventions
cases of study
Patients is diabetes whether recently discovered or long standing diabetes
Intervention: Gliflozin
controls of study
prediabetics ,or patients with clinical manifestations of insulin resistance eg acanthosis negricans
Intervention: Gliflozin
Outcomes
Primary Outcomes
prevention of diabetic complications
Time Frame: 5 years
glomerular filtration rate will be measured at the beginning of the study and at the end